Risk Factors for Nosocomial Gastrointestinal Bleeding and Use of Acid-Suppressive Medication in Non-Critically Ill Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
It is unknown whether there exist certain subsets of patients outside of the intensive care unit in whom the risk of nosocomial gastrointestinal bleeding is high enough that prophylactic use of acid-suppressive medication may be warranted.
To identify risk factors for nosocomial gastrointestinal bleeding in a cohort of non-critically ill hospitalized patients, develop a risk scoring system, and use this system to identify patients most likely to benefit from acid suppression.
Adult patients admitted to an academic medical center from 2004 through 2007. Admissions with a principal diagnosis of gastrointestinal bleeding or a principal procedure code for cardiac catheterization were excluded.
Medication, laboratory, and other clinical data were obtained through electronic data repositories maintained at the medical center. The main outcome measure—nosocomial gastrointestinal bleeding occurring outside of the intensive care unit—was ascertained via ICD-9-CM coding and confirmed by chart review.
Of 75,723 admissions (median age = 56 years; 40 % men), nosocomial gastrointestinal bleeding occurred in 203 (0.27 %). Independent risk factors for bleeding included age > 60 years, male sex, liver disease, acute renal failure, sepsis, being on a medicine service, prophylactic anticoagulants, and coagulopathy. Risk of bleeding increased as clinical risk score derived from these factors increased. Acid-suppressive medication was utilized in > 50 % of patients in each risk stratum. Our risk scoring system identified a high risk group in whom the number-needed-to-treat with acid-suppressive medication to prevent one bleeding event was < 100.
In this large cohort of non-critically ill hospitalized patients, we identified several independent risk factors for nosocomial gastrointestinal bleeding. With further validation at other medical centers, the risk model derived from these factors may help clinicians to direct acid-suppressive medication to those most likely to benefit..
- Cook, DJ, Reeve, BK, Guyatt, GH (1996) Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275: pp. 308-314 CrossRef
- Herzig, SJ, Vaughn, BP, Howell, MD, Ngo, LH, Marcantonio, ER (2011) Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med 171: pp. 991-997 CrossRef
- Therapeutic, ASHP (1999) Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 56: pp. 347-379
- Qadeer, MA, Richter, JE, Brotman, DJ (2006) Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med 1: pp. 13-20 CrossRef
- Ben-Menachem, T, Fogel, R, Patel, RV (1994) Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 121: pp. 568-575 CrossRef
- Cook, DJ, Fuller, HD, Guyatt, GH (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330: pp. 377-381 CrossRef
- Schuster, DP, Rowley, H, Feinstein, S, McGue, MK, Zuckerman, GR (1984) Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 76: pp. 623-630 CrossRef
- Nikolsky, E, Mehran, R, Dangas, G (2007) Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 28: pp. 1936-1945 CrossRef
- Bhatt, DL, Cryer, BL, Contant, CF (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363: pp. 1909-1917 CrossRef
- Ray, WA, Murray, KT, Griffin, MR (2010) Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med 152: pp. 337-345 CrossRef
- Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40: pp. 373-383 CrossRef
- Quan, H, Sundararajan, V, Halfon, P (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 43: pp. 1130-1139 CrossRef
- CCS. H. Healthcare Cost and Utilization Project (HCUP). December 2009; www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.
- Cook, D, Heyland, D, Griffith, L, Cook, R, Marshall, J, Pagliarello, J (1999) Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med. Dec 27: pp. 2812-2817 CrossRef
- Pimentel, M, Roberts, DE, Bernstein, CN, Hoppensack, M, Duerksen, DR (2000) Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol 95: pp. 2801-2806 CrossRef
- Gall, JR, Mignon, FC, Rapin, M (1976) Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet. 142: pp. 377-380
- Hastings, PR, Skillman, JJ, Bushnell, LS, Silen, W (1978) Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 298: pp. 1041-1045 CrossRef
- Fiddian-Green, RG, McGough, E, Pittenger, G, Rothman, E (1983) Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration. Gastroenterology 85: pp. 613-620
- Estruch, R, Pedrol, E, Castells, A, Masanes, F, Marrades, RM, Urbano-Marquez, A (1991) Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol 26: pp. 819-826 CrossRef
- Aseeri, M, Schroeder, T, Kramer, J, Zackula, R (2008) Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103: pp. 2308-2313 CrossRef
- Dial, S, Alrasadi, K, Manoukian, C, Huang, A, Menzies, D (2004) Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 171: pp. 33-38
- Herzig, SJ, Howell, MD, Ngo, LH, Marcantonio, ER (2009) Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 301: pp. 2120-2128 CrossRef
- Howell, MD, Novack, V, Grgurich, P (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170: pp. 784-790 CrossRef
- Risk Factors for Nosocomial Gastrointestinal Bleeding and Use of Acid-Suppressive Medication in Non-Critically Ill Patients
Journal of General Internal Medicine
Volume 28, Issue 5 , pp 683-690
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- gastrointestinal bleeding
- acid suppression
- antiulcer agents
- Industry Sectors
- Author Affiliations
- 1. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
- 5. Division of General Medicine, Baystate Medical Center, Springfield, MA, USA
- 6. Tufts University School of Medicine, Boston, MA, USA
- 2. Division of Pulmonary and Critical Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
- 3. Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
- 4. Division of Gerontology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA